Mydecine Innovations Group (NEO: MYCO) (OTCMKTS: MYCOF) is a psychedelics company that The Dales Report has been watching closely this past year. This episode we host William Cook, Interim CEO and Technical Director of the subsidiary company, MindLeap Health.
Here’s some highlights from the interview:
MindLeap a virtual health technology platform, says Cook
For those who may have missed earlier conversations about MindLeap from the Mydecine interviews, the initial version of the MindLeap app launched last fall. MindLeap, Cook says, is intended to be a virtual health platform that connects users with mental health professionals and introduces them to the idea of psychedelic integration.
Read More
